Category «Patent»

BICTEGRAVIR, NEW PATENT, WO 2018005328, CONCERT PHARMA

It’s only fair to share… BICTEGRAVIR, NEW PATENT, WO 2018005328, CONCERT PHARMA WO2018005328) DEUTERATED BICTEGRAVIR  CONCERT PHARMACEUTICALS, INC. TUNG, Roger, D.; (US) Concert CEO Roger Tung Novel deuterated forms of bictegravir is claimed.  Gilead Sciences is developing the integrase inhibitor bictegravir as an oral tablet for the treatment of HIV-1 infection. This invention relates to …

WO-2018001353, APREMILAST, NEW PATENT, ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD

It’s only fair to share… WO-2018001353, APREMILAST, NEW PATENT, ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD  (WO2018001353) METHOD FOR PREPARING APREMILAST ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD DU, Xiaoqiu; (CN). ZHOU, Lianchao; (CN). LIU, Jiegen; (CN) https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2018001353&recNum=1&maxRec=&office=&prevFilter=&sortOption=&queryString=&tab=FullText EN)Method one: (S) -1- (3-ethoxy-4-methoxyphenyl) -2- (methylsulfonyl) ethylamine N-acetyl-L-leucine salt of formula II is reacted with 3-acetylaminophthalic anhydride of formula III …

Pexidartinib, New Patent, WO 2017215521, Crystal Pharmatech Co Ltd

It’s only fair to share… Pexidartinib, New Patent, WO, 2017215521, Crystal Pharmatech Co Ltd (WO2017215521) PLX3397 HYDROCHLORIDE CRYSTAL FORM, PREPARATION METHOD THEREFOR AND USE THEREOF https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017215521 CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD INVENTORS CHEN, Minhua; (CN). ZHANG, Yanfeng; (CN). ZOU, Po; (CN). ZHANG, Xiaoyu; (CN) Novel crystalline forms of PLX3397 hydrochloride (designated as Forms CS2 and …

ALCAFTADINE, WO 2017211246, NEW PATENT, SHENZHEN TARGETRX, INC.

It’s only fair to share… Alcaftadine NEW PATENT https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017211246&redirectedID=true WO-2017211246, SHENZHEN TARGETRX, INC. SUBSTITUTED FUSED IMIDAZOLE CYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF WANG, Yihan; (CN). XING, Qingfeng; (CN) Novel deuterated analogs of substituted fused imidazole cyclic compounds, particularly alcaftadine are histamine H1-receptor antagonists and mast cell stabilizers, useful for treating allergy and nasal congestion. The present …

Enclomiphene citrate, New patent, WO 2017182097, F.I.S. – FABBRICA ITALIANA SINTETICI S.P.A

It’s only fair to share… Enclomiphene citrate, New patent, WO 2017182097, F.I.S. – FABBRICA ITALIANA SINTETICI S.P.A WO-2017182097 F.I.S. – FABBRICA ITALIANA SINTETICI S.P.A CARUANA, Lorenzo; (IT). PADOVAN, Pierluigi; (IT). DAL SANTO, Claudio; (IT) https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017182097&recNum=1&maxRec=&office=&prevFilter=&sortOption=&queryString=&tab=PCTDescription Enclomiphene citrate is an active pharmaceutical ingredient currently under evaluation in clinical phase III for the treatment of secondary hypergonadism. …

WO 2017163257, NEW PATENT, IBRUTINIB, IND-SWIFT LABORATORIES LIMITED

It’s only fair to share… WO2017163257) PROCESS FOR PREPARING PURE LH-PYRAZOLO[3,4-D] PYRIMIDINE DERIVATIVE https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017163257&recNum=1&maxRec=145&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=FP%3A%28IND+SWIFT%29&tab=PCTDescription IND-SWIFT LABORATORIES LIMITED ARUL, Ramakrishnan; (IN). SARIN, Gurdeep Singh; (IN). WAS, Sandeep; (IN). KUMAR, Vishal; (IN) The present invention relates to an efficient and industrially advantageous process for the preparation of pure lH-pyrazolo[3,4-d] pyrimidine derivative. In particular the present invention provides …

Imigliptin dihydrochloride, Xuanzhu Pharma Co Ltd, NEW PATENT, WO 2017107945

It’s only fair to share…   Imigliptin dihydrochloride, Xuanzhu Pharma Co Ltd, NEW PATENT, WO 2017107945 https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017107945&redirectedID=true Applicants: XUANZHU PHARMA CO.,LTD. [CN/CN]; 2518, Tianchen Street, National High-tech Development Zone Jinan, Shandong 250101 (CN) Inventors: SHU, Chutian; (CN). WANG, Zhenhua; (CN) The present invention relates to a crystalline form of benzoate of a dipeptidyl peptidase-IV inhibitor, a method for preparing …

QUILSECONAZOLE, VT 1129, New Patent, WO, 2017049080, Viamet

It’s only fair to share…   VT 1129 BENZENE SULFONATE CAS 1809323-18-9   VT 1129 1340593-70-5 CAS MF C22 H14 F7 N5 O2, MW 513.37 2-Pyridineethanol, α-(2,4-difluorophenyl)-β,β-difluoro-α-(1H-tetrazol-1-ylmethyl)-5-[4-(trifluoromethoxy)phenyl]-, (αR)- R ISOMER ROTATION + QUILSECONAZOLE, VT-1129 Viamet, in collaboration with Therapeutics for Rare and Neglected diseases, is investigating quilseconazole benzenesulfonate (VT-1129), a small-molecule lanosterol demethylase (CYP51) inhibitor, developed using the company’s …

How to Apply for an International Patent

It’s only fair to share… How to Apply for an International Patent Part1 Determining the Patentability of your Invention 1Determine if you have a patentable invention. U.S. law sets forth the following requirements for something that can be patented: It must be invented or discovered by a person; It must be a new and useful …

DRAFTING A NON-PROVISIONAL PATENT APPLICATION

It’s only fair to share… DRAFTING A NON-PROVISIONAL PATENT APPLICATION! Part1 Determining the Patentability of your Invention 1Determine if you have a patentable invention. U.S. law sets forth the following requirements for something that can be patented: It must be invented or discovered by a person; It must be a new and useful process, machine, …